期刊文献+

固相转染HPV16-siRNA对荷宫颈癌细胞SiHa小鼠瘤体体积及P53、P16表达的影响 被引量:6

siRNA inhibits HPV16-DNA replication,tumor volume and expression of P16 and P53 in SCID mice with SiHa cell cervical carcinoma in vivo
下载PDF
导出
摘要 目的:观察靶向基因治疗后不同时点荷宫颈癌细胞小鼠HPV16-DNA、瘤体体积、P53及P16蛋白的变化,探讨在体固相转染HPV16-siRNA的有效性。方法:采用SiHa细胞皮下注射建立荷宫颈癌细胞SCID小鼠模型。制备HPV16靶向siRNA-Lipo2000-卡波姆凝胶。将40只荷宫颈癌细胞SCID小鼠随机分为对照组8只和研究组32只和研究组使用HPV16靶向siRNA-Lipo2000-卡波姆凝胶进行基因治疗,对照组仅使用Lipo2000-卡波姆凝胶处理;分别于治疗后4 d、8 d、12 d、16 d处死小鼠,每个时点研究组处死8只、对照组处死2只。PCR检测两组小鼠瘤体中HPV16-DNA滴度,测各时点的瘤体体积,常规病理切片检测肿瘤细胞形态,免疫组化检测P16及P53的表达。结果:(1)研究组治疗后8 d及12 d时点瘤体内HPV16-DNA明显降低,与对照组之间的差异显著(P<0.05),4 d及16 d 2个时点与对照组之间的差异不显著(P>0.05);(2)治疗后12 d瘤体平均体积明显缩小,与对照组之间的差异显著(P<0.05);(3)转染后12 d肿瘤细胞核异质性较对照组减轻,核浆比例减小;(4)P16的表达强度在各时点研究组与对照组之间的差异不显著(P>0.05);治疗后8 d及12 d研究组P53的表达强度明显降低,与对照组之间的差异显著(P<0.05)。结论:SCID小鼠所荷宫颈癌细胞瘤体经靶向转染HPV16-siRNA后8 d及12 d时点瘤体内HPV16-DNA和P53均较对照组明显下降,12 d瘤体体积较对照组明显下降;在体固相转染siRNA可以在一定时段内有效抑制HPV-DNA的复制及肿瘤的生长速度。 AIM: To investigate the effect of targeting gene therapy on mouse SiHa cell cervical carcinoma by transfecting siRNA into the tumor with solid-phase method in vivo. METHODS: A sense strand siRNA(21 nt) for human papilloma virus type 16(HPV16) was designed.siRNA-Lipo2000-carbomer gum was prepared.Forty SCID mice with SiHa cell cervical carcinoma were divided into experimental group(n=32) and control group(n=8).The diameter and volume of the tumors were measured before treatment.The mice in experimental group were treated with siRNA-Lipo 2000-carbomer gum for 7 d.The control mice were treated with Lipo 2000-carbomer gum for 7 d.The mice in experimental group and control group were sacrificed at the time points of 4 d,8 d,12 d and 16 d after treatment.The diameter and volume of the tumors were measured again.The HPV16-DNA in the tumor tissues was measured by PCR.The protein levels of P16 and P53 in the tumors were determined by the method of immunohistochemistry. RESULTS: Compared with control group,the titer of HPV16-DNA decreased significantly at the time points of 8 d and 12 d after transfection in experimental group(P〈0.05).The protein expression of P16 in experimental group showed decreased tendency 8 d and 12 d after transfection,but without statistical difference.The protein expression of P53 significantly decreased 8 d and 12 d after transfection.The tumor volume in experimental group was significantly decreased as compared to that in control group at the time point of 12 d(P〈0.05).Transfection of siRNA for 12 d resulted in attenuating dyskaryosis and karyoplasmic ratio of the tumor cells.CONCLUSION: Solid-phase transfaction of siRNA in vivo inhibits HPV-DNA replication and growth of SiHa cell cervical carcinoma.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第3期509-513,共5页 Chinese Journal of Pathophysiology
基金 广东省医学科研基金资助项目(No.A2008142)
关键词 宫颈肿瘤 RNA干扰 人乳头状瘤病毒 P53蛋白 P16蛋白 Cervix neoplasms RNA interference Human papilloma virus Protein P53 Protein P16
  • 相关文献

参考文献18

  • 1Jiang M, Milner J. Selective silencing of viral gene expression in HPV - positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference [ J ]. Oncogene, 2002, 21 (39) : 6041 -6048.
  • 2Bousarghin L, Touze A, Gaud G, et al. Inhibition of cervical cancer cell growth by human papillomavirus virus - like particles packaged with human papillomavirus oncoprotein short hairpin RNAs[J]. Mol Cancer Ther, 2009, 8 (2) : 357 - 365.
  • 3官立丽,彭芝兰,牛晓宇.HPV16 E6小干扰RNA对人宫颈癌裸鼠移植瘤的抑制作用[J].中华肿瘤杂志,2007,29(12):894-897. 被引量:3
  • 4廖百花,冯亦军,肖小敏.兔宫颈固相转染靶向HPV16 siRNA抑制荷宫颈癌SCID小鼠HPV的复制[J].中国病理生理杂志,2010,26(4):695-699. 被引量:3
  • 5Bermtudez - Morales VH, Peralta - Zaragoza O, Guzman-Olea E, et al. HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo [ J ]. Tumor Biol, 2009,30 (2) :61 -72.
  • 6赵艳忠,张为远.人宫颈鳞状细胞癌裸鼠移植模型的建立及分析[J].中国妇幼保健,2010,25(27):3970-3973. 被引量:3
  • 7Mulvany N J, Mien DG, Wilson SM. Diagnostic utility of INK4a p16^1NK4a:a reappraisal of its use in cervical biopsies[J]. Pathology,2008,40(4) :335 - 344.
  • 8Lung FW, Shu BC, Kao WT, et al. Association of DRIM uVNTR and TP53 codon 72 polymorphisms with 6chizo- phrenia: a casecontrol study [ J ]. BMC Med Genet, 2009,10:147.
  • 9Michalak EM, ViUunger A, Adams JM, et al. In several cell types tumor suppressor P53 induces apoptosis largely via Puma but Noxa can contribute [ J ]. Cell Death Differ, 2008, 15(6) :1019 - 1029.
  • 10周坚红,陈怀增,程琪,谢幸.HPV16E7肽疫苗对人免疫重建荷人宫颈癌细胞株SiHa细胞SCID鼠免疫功能的影响[J].现代妇产科进展,2005,14(5):353-357. 被引量:1

二级参考文献70

共引文献413

同被引文献73

  • 1张建明,周杨杨,程建平,金跃.328例宫颈病变妇女高危型人乳头瘤病毒感染及基因型分析[J].临床输血与检验,2011,13(2):117-120. 被引量:16
  • 2欧阳密霞,胡媛,曾飞.ASPP2,iASPP和p53在宫颈癌组织中的表达及意义[J].中南大学学报(医学版),2015,40(3):256-260. 被引量:8
  • 3张军,张旭,许凯,傅斌,郎斌,胡建庭,艾星,史涛坪,朱宏刚,陈军.膀胱移行细胞癌患者血浆p14基因异常甲基化检测的意义[J].中华实验外科杂志,2007,24(3):333-335. 被引量:6
  • 4van Lohuizen M, Verbeek S, Scheijen B, et al. Identification of cooperating oncogenes in Ep,- myc transgenic mice by provirus tagging[ J]. Cell, 1991,65 (5) :737 - 752.
  • 5Reinisch C, Kandutsch S, Uthman A, et al. BMI - 1 : a protein expressed in stem cells, specialized ceils and tumors of the gastrointestinal tract [ J ]. Histol Histopathol, 2006,21 (11) :1143 - 1149.
  • 6Park IK,Morrison SJ, Clarke MF. Bmil, stem cells, and senescence regulation [ J ]. J Clin Invest, 2004,113 ( 2 ) : 175 - 179.
  • 7Liu Y, Yang Y, Xu H, et al. Implication of USP22 in the regulation of BMI - 1, c - Myc, p16^INK4a, p14ARF, and cyclin D2 expression in primary eoloreetal carcinomas [ J ]. Diagu Mol Pathol,2010,19 (4) : 194 - 200.
  • 8Qin ZK, Yang JA, Ye YL, et al. Expression of Bmi - 1 is a prognostic marker in bladder cancer[J].BMC Cancer, 2009,9:61.
  • 9Breuer RH, Snijders PJ, Sutedja GT, et al. Expression of the p16INK4a gene product, methylation of the p16INK4a promoter region and expression of the polycomb - group gene BMI - 1 in squamous cell lung carcinoma and premalignant endo - bronchial lesions [ J ]. Lung Cancer ;2005,48 ( 3 ) : 299 - 306.
  • 10Silva J, Garcia JM, Pena C, et al. Implication of poly- comb members Bmi -1 ,Mel- 18, and Hpc-2 in the regulation of p16INK4a, p14ARt, h- TERT, and c- Myc expression in primary breast carcinomas [ J ]. Clin Cancer Res, 2006,12(23) :6929 -6936.

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部